Paper17374
Inhibition of dopamine synthesis in chronic schizophrenia. Clinical ineffectiveness of metyrosine.
Nasrallah HA and 7 others. Arch Gen Psychiatry, 1977. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of dopamine synthesis in chronic schizophrenia. Clinical ineffectiveness of metyrosine. Papers, record 17374. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17374
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of dopamine synthesis in chronic schizophrenia. Clinical ineffectiveness of metyrosine.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Chemistry | Major topic |
| Dopamine | Major topic |
| Methyltyrosines | Major topic |
| Schizophrenia | Major topic |
| Adult | |
| Antipsychotic Agents | |
| Brain | |
| Chronic Disease | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Drug Synergism | |
| Humans | |
| Male | |
| Phenothiazines | |
| Psychiatric Status Rating Scales | |
| Schizophrenic Psychology | |
| Tyrosine 3-Monooxygenase |
Source PubMed
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37822367 | Metyrosine-associated endocrinological changes in pheochromocytoma and paraganglioma. | Endocr Oncol | 2023 | https://conductscience.org/library/papers/37822367 | PubMed |
| 33693908 | The Role for Metyrosine in the Treatment of Patients With Pheochromocytoma and Paraganglioma. | J Clin Endocrinol Metab | 2021 | https://conductscience.org/library/papers/33693908 | PubMed |
| 22202971 | The protective effects of metyrosine, lacidipine, clonidine, and moxonidine on kidney damage induced by unilateral ureteral obstruction in rats. | Surg Today | 2012 | https://conductscience.org/library/papers/22202971 | PubMed |
| 7857586 | Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function. | J Neural Transm Gen Sect | 1994 | https://conductscience.org/library/papers/7857586 | PubMed |
| 40288 | The relative role of dopamine and norepinephrine receptor blockade in the action of antipsychotic drugs: metoclopramide, thiethylperazine, and molindone as pharmacological tools. | Psychopharmacology (Berl) | 1979 | https://conductscience.org/library/papers/40288 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PRL | 5617 | PubTator's text mining | https://conductscience.org/library/genes/5617 | NCBI Gene |
| TH | 7054 | PubTator's text mining | https://conductscience.org/library/genes/7054 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17374
GET https://conductscience.org/api/papers/v1/17374/authors